Retatrutide 30mg Peptide Pen is a cutting-edge, triple-incretin research peptide offered in a prefilled, high-dosage format. As a potent GIP, GLP-1, and glucagon receptor agonist, it’s being extensively studied for extreme fat reduction, glucose optimization, and long-term metabolic enhancement in clinical models.
This ultra-concentrated 30mg pen is ideal for researchers seeking extended study durations, improved compliance, and consistent subcutaneous dosing without reconstitution. Early studies suggest it offers **unprecedented fat loss potential**, outperforming Semaglutide and Tirzepatide in total weight and visceral fat reduction.
Key Characteristics
| Feature | Description |
|---|---|
| Compound | Retatrutide |
| Form | Prefilled Injectable Pen (30mg total) |
| Mechanism | Triple Receptor Agonist (GIP / GLP-1 / Glucagon) |
| Primary Use | Advanced fat loss, metabolic optimization, research on obesity/insulin resistance |
| Benefit | Maximum efficacy in long-term fat reduction and appetite suppression |
Benefits
- Highest available dosage in ready-to-use pen format
- Powerful appetite regulation and lipolysis stimulation
- Enhances insulin sensitivity and blood glucose control
- Eliminates need for daily reconstitution or mixing
- Ideal for extended-duration clinical-style fat loss studies
Reviews
There are no reviews yet.